¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

15th International Congress on Systemic Lupus Erythematosus and the 43rd Korean College of Rheumatology Annual Scientific Meeting & 17th International Symposium (LUPUS & KCR 2023)(1ÀÏÂ÷) : 2023-05-17

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

15th International Congress on Systemic Lupus Erythematosus and the 43rd Korean College of Rheumatology Annual Scientific Meeting & 17th International Symposium (LUPUS & KCR 2023)(1ÀÏÂ÷) : 2023-05-17
±³À°ÀÏÀÚ : 2023-05-17
±³À°Àå¼Ò : ÄÚ¿¢½º

±³À°ÁÖÁ¦ : 15th International Congress on Systemic Lupus Erythematosus and the 43rd Korean College of Rheumatology Annual Scientific Meeting & 17th International Symposium (LUPUS & KCR 2023)(1ÀÏÂ÷)

ÁÖÃÖ±â°ü : ´ëÇÑ·ù¸¶Æ¼½ºÇÐȸ
´ã´çÀÚ : ´ëÇÑ·ù¸¶Æ¼½ºÇÐȸ
¿¬¶ôó : 02-794-2630  

À̸ÞÀÏ : webmaster@rheum.or.kr

±³À°Á¾·ù : ³»°ú, ¼Ò¾Æû¼Ò³â°ú, Á¤Çü¿Ü°ú, ¿µ»óÀÇÇаú, Áø´Ü°Ë»çÀÇÇаú, °¡Á¤ÀÇÇаú

Âü¼®¿¹»óÀÎ : 1600¸í
Èñ¸ÁÆòÁ¡ : 2Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 5 ½Ã°£ 0ºÐ

¼¼ºÎ¼ö°­·á : 300,000¿ø  

ºñ°í »çÀüµî·Ï: Àü¹®ÀÇ, ¹Ú»ç±Þ ¿¬±¸¿ø, ÀüÀÓÀÇ 300,000¿ø / Àü°øÀÇ, °£È£»ç, ¼®»ç±Þ ÀÌÇÏ ¿¬±¸¿ø 160,000¿ø ÇöÀåµî·Ï: Àü¹®ÀÇ, ¹Ú»ç±Þ ¿¬±¸¿ø, ÀüÀÓÀÇ 360,000¿ø / Àü°øÀÇ, °£È£»ç, ¼®»ç±Þ ÀÌÇÏ ¿¬±¸¿ø 200,000¿ø

±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 05¿ù 17ÀÏ ±×·£µåº¼·ë 101 13:30~13:50 15-year outcome of Chinese patients with systemic lupus erythematosus: Data from Chinese Systemic Lupus Erythematosus Treatment and Research group Xinping Tian(Peking Union Medical College)

±³À°½Ã°£ 05¿ù 17ÀÏ ±×·£µåº¼·ë 101 13:50~14:10 Treatment of neuropsychiatric systemic lupus erythematosus: Clinical challenges and future perspectives Pingting Yang(China Medical Univ.)

±³À°½Ã°£ 05¿ù 17ÀÏ ±×·£µåº¼·ë 101 14:10~14:30 The treatment strategy of systemic lupus erythematosus associated pulmonary arterial hypertension: Evolving into the future Jiuliang Zhao(Peking Union Medical College)

±³À°½Ã°£ 05¿ù 17ÀÏ ±×·£µåº¼·ë 102 13:30~13:50 Hydroxychloroquine issue Nathalie Costedoat-Chalumeau(Cochin Hosp.)

±³À°½Ã°£ 05¿ù 17ÀÏ ±×·£µåº¼·ë 102 13:50~14:10 Pregnancy Evelyne Vinet(McGill Univ. Health Centre)

±³À°½Ã°£ 05¿ù 17ÀÏ ±×·£µåº¼·ë 102 14:10~14:30 Neuropsychiatric systemic lupus erythematosus Alexandra Legge(Dalhousie Univ.)

±³À°½Ã°£ 05¿ù 17ÀÏ ±×·£µåº¼·ë 105 13:30~13:50 Establishment of the AsiaPacific Lupus Collaboration - Challenges and opportunities Rangi Kandane-rathnayake(Monash Univ.)

±³À°½Ã°£ 05¿ù 17ÀÏ ±×·£µåº¼·ë 105 13:50~14:10 Scientific outcomes from the AsiaPacific Lupus Collaboration - from endpoint validation to survival factors Eric Morand(Monash Univ.)

±³À°½Ã°£ 05¿ù 17ÀÏ ±×·£µåº¼·ë 105 14:10~14:30 Treat to target studies in systemic lupus erythematosus - using real world data to strengthen study design Mandana Nikpour(The Univ. of Melbourne)

±³À°½Ã°£ 05¿ù 17ÀÏ ÄÁÆÛ·±½º·ë 205A+B 15:00~15:30 Treat-to-target Ronald Van Vollenhoven(Amsterdam UMC)

±³À°½Ã°£ 05¿ù 17ÀÏ ±×·£µåº¼·ë 104 15:00~15:12 Introduction and bacterial infection Chi-Chiu Mok(Tuen Mun Hosp.)

±³À°½Ã°£ 05¿ù 17ÀÏ ±×·£µåº¼·ë 104 15:12~15:24 Tuberculosis and non-tuberculosis mycobacterium infection Laniyati Hamijoyo(Univ. of Padjadjaran)

±³À°½Ã°£ 05¿ù 17ÀÏ ±×·£µåº¼·ë 104 15:24~15:36 Pneumocystis pneumonitis Koshiro Sonomoto(Univ. of Occupational and Environmental Health)

±³À°½Ã°£ 05¿ù 17ÀÏ ±×·£µåº¼·ë 104 15:36~15:48 Viral infections (except for Covid-19) Kenji Oku(Kitasato Univ.)

±³À°½Ã°£ 05¿ù 17ÀÏ ±×·£µåº¼·ë 104 15:48~16:00 Covid-19 Lai Shan Tam(The Chinese Univ. of Hong Kong)

±³À°½Ã°£ 05¿ù 17ÀÏ ÄÁÆÛ·±½º·ë 209A+B 15:00~15:30 Disease activity and damage index Matthias Schneider(Heinrich-Heine-Universität Düsseldorf)

±âŸ 05¿ù 17ÀÏ ¿ÀµðÅ丮¿ò 17:00~17:05 Welcome address ¹è»óö(ÇѾç´ëÇб³)

±âŸ 05¿ù 17ÀÏ ¿ÀµðÅ丮¿ò 17:05~17:10 Congratulatory address À̽ż®(Àü³²´ëÇб³)

±âŸ 05¿ù 17ÀÏ ¿ÀµðÅ丮¿ò 17:10~17:20 Overview of LUPUS & KCR 2023 ¹è»óö(ÇѾç´ëÇб³)

±âŸ 05¿ù 17ÀÏ ¿ÀµðÅ丮¿ò 17:20~17:25 Congratulatory address ¿À¼¼ÈÆ(¼­¿ïƯº°½ÃÀå)

±âŸ 05¿ù 17ÀÏ ¿ÀµðÅ丮¿ò 17:25~17:30 Teaser of the FoUr ½É½Âö(Ãæ³²´ëÇб³)

±âŸ 05¿ù 17ÀÏ ¿ÀµðÅ丮¿ò 17:30~17:40 The Light ¾çÁö¿ì(Çѱ¹¿¹¼úÁ¾ÇÕÇб³)

±âŸ 05¿ù 17ÀÏ ¿ÀµðÅ丮¿ò 17:40~18:00 The Words David McCann(Harvard Univ.)

±âŸ 05¿ù 17ÀÏ ¿ÀµðÅ丮¿ò 18:00~18:20 The Height À¯ÇöÁØ(À¯ÇöÁØ °ÇÃà»ç¹«¼Ò)

±âŸ 05¿ù 17ÀÏ ¿ÀµðÅ丮¿ò 18:20~18:30 The Barrier ³ë¼öÇö(°¡¼ö)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û 2023³â ±Ýõ±¸ÀÇ»çȸ 1Â÷ ¿¬¼ö±³À° : 2023-05-17
´ÙÀ½±Û °­³²¼¼ºê¶õ½ºº´¿ø ¾È°ú Áö¿ªÀÇ»ç Áý´ãȸ(½º¸¶Æ® ³ì³»Àå ¹æ¼ö À¯Ãâ ÀåÄ¡ ½Ã½ºÅÛÀÇ °³¹ß) : 2023-05-16
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
21122 ¼­¿ï Çѱ¹¹é³»Àå±¼Àý¼ö¼úÇÐȸ 2024 KSCRS Annual Symposium(2ÀÏÂ÷) : 2024-07-14 0 62 2024-06-19
21121 ¼­¿ï Á¦8ȸ ÀüÀÓÀÇ Àü°øÀÇ °³¿øÀǸ¦ À§ÇÑ °£Áúȯ ¿¬¼ö°­Á : 2024-07-14 0 85 2024-06-19
21120 ¼­¿ï 24³âµµ ´ëÇѱâ´ÉÀÇÇÐȸ Çϰ迬¼ö°­Á : 2024-07-14 0 44 2024-06-19
21119 ¼­¿ï ´ëÇÑÇ÷°üÇÐȸ KOVAS 2024 Summer Conference (2ÀÏÂ÷) : 2024-07-13 0 59 2024-06-19
21118 ÀüºÏ 2024³â ´ëÇÑ»ý¹°Ä¡·áÁ¤½ÅÀÇÇÐȸ Çϰ迬¼ö±³À° : 2024-07-13 0 60 2024-06-19
21117 ¼­¿ï ´ëÇÑÁ·ºÎÁ·°üÀýÇÐȸ - Á¦1ȸ ´ç´¢¹ß ½ÉÆ÷Áö¾ö : 2024-07-13 0 29 2024-06-19
21116 ¼­¿ï õ½Ä¿¬±¸È¸ Workshop 2024 : 2024-07-13 0 32 2024-06-19
21115 ¼­¿ï 2024 Àç°ü·ùÄ¡·á¿¬±¸È¸ Ãá°è½ÉÆ÷Áö¿ò ¹× ÃÑȸ : 2024-07-13 0 59 2024-06-19
21114 ¼­¿ï Çѱ¹¹é³»Àå±¼Àý¼ö¼úÇÐȸ 2024 KSCRS Annual Symposium(1ÀÏÂ÷) : 2024-07-13 0 51 2024-06-19
21113 ¼­¿ï 2024 ´ç´¢º´½ÅÁõ ½ÉÆ÷Áö¾ö : 2024-07-13 0 22 2024-06-19
21112 ¼­¿ï ´ëÇÑÇ÷°üÇÐȸ KOVAS 2024 Summer Conference (1ÀÏÂ÷) : 2024-07-12 0 22 2024-06-19
21111 ¼­¿ï 2024 ´ëÇѽÅÃéÀåÀ̽Ŀܰú¿¬±¸È¸ ÇÏ°è Çмú´ëȸ : 2024-07-12 0 28 2024-06-19
21110 ¼­¿ï ´ëÇÑ¿ì¿ïÁ¶¿ïº´ÇÐȸ Çϰ迬¼ö±³À° : 2024-07-12 0 52 2024-06-19
21109 ¼­¿ï (¿Â¶óÀÎ) ´ëÇÑÁ¤Çü¿Ü°úÇÐȸ – Á¦5Â÷ Àå¾ÖÆÇÁ¤ ¿Â¶óÀÎ ½ÉÆ÷Áö¾ö : 2024-07-07 0 18 2024-06-19
21108 ¼­¿ï 2024³â ´ëÇѺñ´¢ºÎÀΰúÇÐȸ Á¦27Â÷ Çмú´ëȸ (¿ÀÇÁ¶óÀÎ) : 2024-07-07 0 50 2024-06-19
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷